2026 U.S. Dietary Supplement Consumer Report

A Comprehensive National Study of How Americans Buy, Use, and Think About Supplements — and What It Reveals About the Future of Personal Health

Methodology & Survey Overview

This report is based on a nationally representative survey of 4,847 U.S. adults aged 18 and older, conducted between January and March 2026. The survey was designed to capture a statistically accurate portrait of American dietary supplement behavior across all major demographic dimensions — including age, gender, household income, education level, geographic region, and health status.

Participants were recruited through a stratified random sampling methodology using a combination of online panels and telephone interviews, weighted to match 2025 U.S. Census Bureau population estimates. The margin of error is ±1.4 percentage points at the 95% confidence level.

Supplement use was defined broadly as intentional consumption of any product sold as a dietary supplement, including vitamins, minerals, botanicals and herbal extracts, probiotics, amino acids, protein powders, and specialty compounds, taken at least once in the past 30 days. Respondents who reported use were then asked a battery of follow-up questions about specific products, spending, motivations, purchasing channels, format preferences, and quality considerations.

Unless otherwise noted, all percentage data refers to the full survey sample of U.S. adults. Where data refers to supplement users specifically, it is noted as such.

The Big Picture: Who Takes Supplements in America

The headline finding of the 2026 U.S. Dietary Supplement Consumer Report is both striking and, on reflection, unsurprising: seven in ten American adults — 69.4% of the survey population — report taking at least one dietary supplement in the past 30 days. That figure represents a 5.2 percentage point increase from comparable surveys conducted in 2022 and marks the highest documented rate of supplement use in American history.

The implications are significant. Extrapolated to the U.S. adult population, this suggests that approximately 183 million Americans are active supplement users — a consumer base larger than the population of every country in the world except China and India. The industry serving this population generated an estimated $68.2 billion in U.S. retail sales in 2025, with projections pointing toward $78.4 billion by 2027.

But headline use rates tell only part of the story. The more revealing finding is how supplement use has changed in its character — not just in its prevalence. The supplement user of 2026 is taking more products, spending more money, asking harder questions about quality and evidence, and reaching for an increasingly diverse range of compounds that would have been largely unknown outside specialist wellness circles just five years ago.

Overall Use Rate Snapshot

Metric	2022	2024	2026	Change (2022–2026)
% of U.S. adults using supplements	64.2%	66.8%	69.4%	+5.2 pts
Average # of supplements per user	2.8	3.2	3.7	+32%
Average monthly spend (users only)	$44	$51	$57	+30%
% purchasing primarily online	49%	55%	61%	+12 pts
% checking third-party certification	28%	38%	49%	+21 pts
% following provider recommendation	37%	40%	41%	+4 pts

The simultaneous rise in use rate, products per user, average spend, and quality scrutiny paints a picture of an industry maturing in both breadth and depth. Americans are not just taking more supplements — they are paying more attention to what those supplements are and whether they're worth taking.

Most Commonly Used Supplements: The Complete National Rankings

When respondents were asked to identify which supplements they had taken in the past 30 days, the distribution reflected both the enduring dominance of traditional micronutrient categories and the rapid rise of newer, functionally specific compounds.

The Top 20 Most Used Supplements Among U.S. Adults (2026)

Rank	Supplement	% of U.S. Adults Using	% Change vs. 2024
1	Multivitamins	52%	+1 pt
2	Vitamin D	44%	+3 pts
3	Omega-3 / Fish Oil	36%	−2 pts
4	Vitamin C	33%	−1 pt
5	Magnesium	31%	+6 pts
6	B-Complex / Vitamin B12	28%	+4 pts
7	Probiotics	26%	+5 pts
8	Turmeric / Curcumin	19%	+2 pts
9	Collagen Peptides	18%	+7 pts
10	Ashwagandha	15%	+8 pts
11	Zinc	22%	−3 pts
12	Iron	14%	0 pts
13	Melatonin	17%	+2 pts
14	Calcium	21%	−4 pts
15	CoQ10	12%	+2 pts
16	Protein Powder (any type)	23%	+3 pts
17	Creatine	11%	+5 pts
18	Berberine	8%	+6 pts
19	Collagen (ingestible)	18%	+7 pts
20	NMN / NR (NAD+ Precursors)	7%	+9 pts

Several findings from this ranking deserve particular attention. Magnesium has climbed six percentage points since 2024, now used by nearly one-third of American adults — growth driven almost entirely by word-of-mouth awareness of its sleep and stress applications rather than medical recommendation. Ashwagandha's eight-point rise makes it one of the fastest-growing established supplements in the survey, now surpassing Iron in overall use. And NAD+ precursors like NMN and nicotinamide riboside — essentially unknown to general consumers three years ago — have broken into the top 20, driven by the mainstreaming of longevity supplementation concepts.

Meanwhile, Calcium's four-point decline reflects an important scientific recalibration: multiple large trials and updated clinical guidelines have moved calcium supplementation from routine recommendation to targeted use for documented deficiency, and the general consumer population appears to have absorbed this shift.

Energy Supplement Deep Dive: America's Productivity Supplement

Of all the functional supplement categories in the 2026 survey, none is more consequential in terms of daily use, consumer expectations, and emerging scientific concerns than the energy supplement category.

38% of U.S. adults — an estimated 100 million people — report using at least one supplement specifically for energy or mental performance in the past 30 days. Among this group, daily use is the norm rather than the exception: 64% of energy supplement users report taking their energy supplements every day, compared to 47% for supplement users overall.

Energy Supplement Usage Profile

Metric	Finding
% of U.S. adults using energy supplements	38%
% who use daily (among energy supp. users)	64%
Average monthly spend on energy supplements	$42
Most common reason for use	Combat general fatigue (74%)
Second most common reason	Improve mental focus (61%)
Third most common reason	Athletic/physical performance (34%)
% who started use in the past 2 years	41%
% who also use prescription stimulants	8%
% who consult a doctor before use	22%

Top Ingredients Used by Energy Supplement Consumers

Ingredient	% of Energy Supp. Users Taking It	Primary Claimed Benefit
Vitamin B Complex	58%	Metabolic energy production
Magnesium (any form)	41%	ATP synthesis, mitochondrial function
Ashwagandha	34%	Stress-related fatigue, HPA axis
Caffeine (supplement form)	29%	Immediate alertness
CoQ10	28%	Mitochondrial support
L-theanine	26%	Focused calm energy
Rhodiola Rosea	18%	Mental fatigue, adaptogenic
Ginseng (Panax)	22%	General vitality
Iron	19%	Oxygen delivery (deficiency-driven)
NMN / NR	14%	Cellular NAD+ and energy aging

The shift from stimulant-dominant energy supplementation toward adaptogen and mitochondrial support is one of the most significant behavioral changes in this year's data. In 2022, caffeine-containing products were the first or second most frequently cited ingredient across all energy supplement users. By 2026, they have dropped to fourth — behind B vitamins, magnesium, and ashwagandha. This shift correlates closely with growing consumer concern about caffeine dependency: 44% of energy supplement users say they are actively trying to reduce their reliance on caffeine, and 38% say the desire to find a "non-stimulant energy solution" drove their most recent supplement purchase.

Age Distribution of Energy Supplement Use

Age Group	% Using Energy Supplements
18–24	41%
25–34	52%
35–44	48%
45–54	38%
55–64	29%
65+	22%

The peak of energy supplement use falls squarely in the 25–34 age cohort — the demographic most likely to be managing career demands, young families, and sleep debt simultaneously. The sharper-than-expected decline after age 44 reflects a complex interaction: older adults are less likely to use stimulant-adjacent products, but those who do use energy supplements in older age groups tend to be the most sophisticated consumers in the category, gravitating toward mitochondrial support and NAD+ approaches rather than B-vitamin blends.

Sleep Supplement Report: A Nation Medicating Its Way to Rest

The sleep supplement category is the single fastest-growing functional category in this year's survey — and one of the most revealing about the broader relationship between American health consciousness and the supplement industry.

31% of U.S. adults report using at least one supplement specifically to support sleep quality or duration in the past 30 days. That figure, representing roughly 82 million Americans, has grown by eleven percentage points in four years. To put the magnitude of this growth in context: in 2019, before the COVID-19 pandemic triggered a global sleep crisis, the comparable figure was approximately 14%.

Sleep Supplement Usage Profile

Metric	Finding
% of U.S. adults using sleep supplements	31%
% who use nightly (among sleep supp. users)	58%
Average monthly spend on sleep supplements	$28
% who began use during/after COVID (2020–2022)	34%
% who also use prescription sleep medication	11%
% who have discussed with a physician	29%
% who report "significant improvement" in sleep	51%
% who report "modest improvement"	31%
% who report no meaningful improvement	18%

Sleep Supplement Product Breakdown

Product	% of Sleep Supp. Users	Avg. Dose	Daily/Nightly %
Melatonin	71%	4.8 mg	68%
Magnesium Glycinate	38%	310 mg	74%
L-Theanine	29%	198 mg	61%
Ashwagandha	22%	380 mg	52%
Valerian Root	18%	440 mg	49%
CBD / Hemp Extract	14%	Variable	41%
GABA	12%	490 mg	58%
5-HTP	9%	96 mg	44%
Tart Cherry Extract	8%	470 mg	38%
Glycine	6%	3,020 mg	62%

One of the most clinically significant findings in the sleep supplement data is the average melatonin dose reported by users: 4.8 mg nightly. This is nearly ten times the 0.3–1 mg dose range that sleep research consistently identifies as physiologically appropriate for circadian signaling, and more than double the 2 mg that most sleep medicine guidelines consider the upper bound for general use. The disconnect between the commercially standard doses sold in most retail settings and what sleep science actually supports represents one of the more actionable consumer protection issues in the current supplement landscape.

Magnesium glycinate's rise is notable and well-supported: its position at 38% of sleep supplement users reflects a genuine alignment between consumer behavior and clinical evidence, with multiple randomized trials demonstrating meaningful improvements in sleep quality, particularly in adults with suboptimal dietary magnesium intake — a category estimated to include nearly half the U.S. adult population.

The 51% of sleep supplement users who report "significant improvement" warrants careful interpretation. This figure almost certainly includes a meaningful placebo effect contribution, particularly for a subjective outcome like sleep quality where expectation shapes experience powerfully. What it genuinely reflects is that a majority of sleep supplement consumers perceive sufficient benefit to continue use — which is itself a meaningful behavioral and commercial reality.

Supplement Spending: The Economics of American Self-Care

The financial dimension of supplement use in 2026 reveals an industry that has successfully moved from the pharmacy budget line to the healthcare budget line in the minds of American consumers — with corresponding implications for how much people are willing to spend.

Annual Supplement Spending Distribution (Users Only)

Monthly Spend Range	% of Supplement Users	Avg. Annual Spend
Under $25/month	24%	~$216
$26–$50/month	31%	~$456
$51–$100/month	28%	~$900
$101–$200/month	12%	~$1,740
Over $200/month	5%	~$3,000+

The weighted average monthly spend among U.S. supplement users is $57, representing an annual investment of $684 per active user. This average masks significant variation: the 17% of users spending over $100 per month — the "high-commitment" segment — accounts for a disproportionate 41% of total category revenue, making their preferences and behavior outsized drivers of product development and innovation investment.

Spending by Gender

Gender	% Using Supplements	Avg. Monthly Spend
Women	72%	$54
Men	67%	$61
Non-binary / other	64%	$58

Men show higher average per-product spending despite a slightly lower use rate — a pattern driven by the sports nutrition and longevity supplement categories, where higher unit costs for products like creatine, NMN, and protein powders pull the male average upward.

Purchasing Channels

Channel	% of Users Who Purchase Here	% of Total Dollar Spend
Online (general e-commerce)	61%	54%
Specialty health retailer	34%	24%
Mass market / pharmacy	28%	14%
Direct from manufacturer	18%	6%
Healthcare provider's office	7%	2%

The shift to online purchasing — now at 61% of users — has profound implications for both quality verification and consumer education. Online purchasing removes the in-store pharmacist consultation that represents one of the historically important informal quality filters in supplement selection. It also exposes consumers to international marketplace platforms where regulatory oversight is inconsistent, and product authenticity is difficult to verify. The 18% who purchase directly from manufacturers represent a quality-seeking segment: direct-to-consumer supplement brands have been among the fastest adopters of third-party certification and transparent ingredient disclosure, and their customers skew toward the most evidence-engaged consumer profiles.

Age Group Analysis: How Supplement Use Changes Across the Lifespan

One of the most strategically useful dimensions of this year's consumer report is its detailed portrait of how supplement behavior — both in terms of what people take and why — changes meaningfully across age cohorts.

Supplement Use and Spending by Age Group (2026)

Age Group	% Using Supplements	Avg. # of Products	Avg. Monthly Spend	Top Supplement
18–24	44%	2.1	$32	Protein powder
25–34	61%	2.8	$54	Multivitamin
35–44	68%	3.4	$64	Vitamin D
45–54	71%	3.8	$71	Magnesium
55–64	74%	4.1	$68	Vitamin D
65+	78%	4.4	$58	Multivitamin

Supplement use rates follow a consistent upward curve with age — rising from 44% among the youngest adults to 78% among those 65 and older. But the nature of that use shifts dramatically across the lifespan.

• 18–24: The youngest supplement cohort is defined primarily by performance and aesthetics motivations. Protein powders, creatine, pre-workout blends, and biotin for hair/nail health dominate this group's supplement profiles. Notably, this is the cohort most likely to have initiated supplement use based on social media influence: 61% of 18–24 supplement users report that a social media video or influencer post was their primary discovery channel for their most recent new supplement, compared to just 9% of adults over 55.
• 25–34: The late-twenties through mid-thirties segment shows the most dramatic inflection in supplement behavior. This age group sees the highest rate of beginning new supplement regimens (41% started a new supplement in the past 12 months), the highest rate of energy supplement use (52%), and the fastest adoption of personalized supplement services (29%). The combination of high productivity pressure, early family formation, and first encounters with non-trivial health concerns creates a powerful motivation cocktail.
• 35–44: Adults in this cohort show the first meaningful transition from performance-oriented to maintenance-oriented supplementation. Vitamin D, omega-3s, and probiotics grow in prominence. So does quality consciousness: this group shows the highest rate of third-party certification checking among all age groups under 55, at 54%.
• 45–54: The decade between 45 and 54 marks a pivotal supplementation transition, heavily influenced by hormonal changes — particularly perimenopausal and menopausal experiences in women — and by growing concern about cardiovascular and cognitive health. Magnesium, CoQ10, collagen, and adaptogens all see their highest use rates in this cohort. Average spending peaks here at $71 per month.
• 55–64: Near-retirees show high supplement use (74%) paired with a notable increase in healthcare provider guidance: 52% of this cohort reports that a physician or pharmacist recommendation influenced their current supplement regimen, the highest rate of any age group.
• 65+: Older Americans are the most consistent supplement users — 78% using supplements, 73% taking them daily — but tend to concentrate on fewer, more established products. Multivitamins, vitamin D, calcium (though declining), and omega-3s dominate. Notably, this group shows the lowest rate of novel supplement adoption: only 12% have tried any supplement introduced to the market in the past two years.

Consumer Motivations: Why Americans Reach for Supplements

Supplement use is, at its core, a behavior driven by motivation — and the motivations Americans report for their supplement use reveal as much about the cultural moment as they do about the science.

Primary Motivations for Supplement Use (Multiple Response — % of All Supplement Users)

Motivation	% of Supplement Users	Change vs. 2022
General health and wellness maintenance	68%	+4 pts
Fill perceived nutritional gaps in diet	52%	−2 pts
Immune system support	47%	−8 pts
Energy and vitality	44%	+9 pts
Bone and joint health	38%	−3 pts
Longevity and healthy aging	34%	+12 pts
Sleep quality improvement	31%	+11 pts
Mental focus and cognitive performance	28%	+10 pts
Gut and digestive health	26%	+6 pts
Stress and mood management	24%	+8 pts
Weight management	22%	−6 pts
Athletic and physical performance	19%	+2 pts

The most striking trend in motivation data is the collapse of immune support as a primary driver and the corresponding rise of longevity, sleep, cognitive, and stress motivations. Immune support peaked at 55% of supplement users in 2022 — a lingering residual of COVID-era supplementation behavior — and has now declined to 47%, still elevated relative to 2019 pre-pandemic levels (37%) but clearly normalizing.

The rise of longevity as a motivation (+12 points) is the most dramatic shift in the motivation landscape and deserves careful context. The word "longevity" now functions in supplement marketing and consumer consciousness as a broad umbrella covering everything from biological age management with NAD+ precursors to simple skin elasticity from collagen peptides. What the data actually reflects is a meaningful cultural shift: a growing cohort of Americans is explicitly thinking about their supplement choices in terms of how they affect the rate and experience of aging, not merely day-to-day health maintenance.

Cognitive performance's 10-point rise is equally striking and tells a specific story about the post-pandemic work environment. Remote work's normalization, the rise of "productivity culture," and growing awareness of conditions like brain fog — formally recognized in long-COVID contexts but experienced diffusely across the population — have made mental performance one of the most commercially potent supplement motivations of the decade.

Motivations by Gender

Motivation	Women	Men
General wellness	71%	65%
Immune support	51%	43%
Longevity/aging	38%	29%
Energy	47%	41%
Athletic performance	12%	28%
Cognitive performance	25%	32%
Sleep	34%	27%
Gut health	29%	23%
Stress/mood	28%	19%

Popular Ingredients in 2026: What's Rising, What's Fading, and What the Science Says

Beyond the rankings of overall supplement use, this year's consumer report tracked the growth trajectories of specific ingredients — both in terms of consumer adoption and in terms of the clinical evidence base that either supports or constrains those trends.

Fastest-Growing Supplement Ingredients by Year-Over-Year Search and Purchase Growth

Ingredient	YoY Consumer Search Growth	YoY Purchase Growth	Evidence Maturity
NMN (Nicotinamide Mononucleotide)	+112%	+89%	Moderate — growing RCT base
Urolithin A	+89%	+74%	Moderate — Phase 2 trials completed
Spermidine	+64%	+51%	Early — small human trials
Berberine	+78%	+63%	Good — multiple metabolic RCTs
Magnesium Glycinate (specific form)	+47%	+44%	Strong — form-specific evidence
Ashwagandha (root extract)	+38%	+36%	Strong — 20+ RCTs
L-Theanine	+52%	+48%	Good — cognitive RCTs
Creatine (cognitive use)	+44%	+39%	Strong — expanding beyond athletic
Lion's Mane Mushroom	+41%	+38%	Moderate — recent RCTs in healthy adults
Postbiotics / Tributyrin	+67%	+54%	Early — growing RCT base

The evidence column in this table tells a story that should matter to consumers but often doesn't: several of the fastest-growing ingredients have moderate or early evidence bases, while several with the strongest evidence are growing more slowly simply because they are less novel. Magnesium glycinate is the clearest example — it has strong, form-specific clinical evidence for sleep quality, muscle function, and cardiovascular markers, yet its 44% purchase growth lags behind less evidence-supported longevity compounds simply because it lacks the narrative excitement of something "new."

Most Declined Ingredients

Some ingredients are losing consumer enthusiasm, whether due to evolving evidence or shifting focus:

Ingredient	YoY Purchase Decline	Primary Driver
Calcium (general population)	−9%	Updated clinical guidelines reducing routine use
High-dose Vitamin E	−14%	Longstanding safety/efficacy concerns
Generic antioxidant blends	−11%	Consumer sophistication; seeking specificity
Echinacea	−7%	Post-COVID immune supplement fatigue
Colloidal silver	−18%	Continued regulatory pressure and safety concerns
Raspberry ketones	−22%	Sustained evidence failure

The decline of generic antioxidant blends is particularly meaningful as a market signal. It reflects a maturing consumer who has absorbed — through health media, healthcare provider conversations, or personal research — the message that nonspecific antioxidant supplementation has not performed as promised in large clinical trials, and who is now seeking more targeted, mechanism-specific interventions.

Supplement Format Preferences: The Gummy Revolution and Its Discontents

How Americans prefer to take their supplements has undergone one of the most visible transformations in the category's history. The gummy supplement format had barely a meaningful market presence fifteen years ago — has exploded into mainstream dominance and is now reshaping product development, manufacturing investment, and quality considerations across the industry.

Supplement Format Preferences (Multiple Response — % of Supplement Users)

Format	% of Users Who Prefer/Use	Change vs. 2022	Typical Limitation
Capsules / Softgels	71%	−4 pts	None significant
Gummies	42%	+18 pts	Sugar content; dose limits; stability
Powders (mix-in)	31%	+5 pts	Palatability; preparation time
Traditional Tablets	28%	−9 pts	Swallowability; dissolution variable
Liquids / Tinctures	14%	+3 pts	Cost; dosing precision
Chewables (non-gummy)	11%	0 pts	—
Sublingual Strips/Sprays	8%	+4 pts	Bioavailability variable
Transdermal Patches	5%	+3 pts	Cost; clinical evidence limited

Capsules and softgels remain the most commonly used format by a wide margin — a position they are unlikely to lose given their flexibility across ingredient types, their established bioavailability profiles, and their compatibility with manufacturing processes that allow for the advanced formulation technologies (liposomal encapsulation, phospholipid complexation, time-release matrices) that are driving the quality tier of the industry forward.

But the gummy format's 18-point rise since 2022 is the undeniable commercial story of the period, and it comes with important caveats that the clinical community is beginning to articulate more loudly.

Why Gummies Are Dominating — and Why It Matters Clinically

Gummies succeed commercially for well-understood reasons: they require no water to consume, they taste pleasant, they remove the psychological barrier of "taking medicine," and they appeal strongly to adults who struggle with tablet or capsule swallowing. The 18–34 demographic shows the highest gummy preference at 58%, compared to just 19% among adults over 65.

The clinical concerns are equally real. Sugar-based gummy matrices impose dose limitations on active ingredients — most gummies contain 2–4g of gummy base per piece, leaving limited room for active compounds, particularly those requiring larger doses. Magnesium, for example, needs 200–400mg of elemental magnesium for meaningful clinical effect; delivering this in palatable gummy form typically requires four to eight individual gummies per dose, a compliance barrier that undermines the convenience advantage.

Gummies also present greater challenges for ingredient stability. Moisture-sensitive compounds, heat-labile vitamins, and live probiotic cultures are all more difficult to maintain in gummy matrices than in capsules, and the sugar and gelatin environment creates potential for ingredient-matrix interactions that can reduce potency over shelf life.

A 2025 independent testing analysis found that gummy supplements were 2.4 times more likely to contain less than 80% of their labeled active ingredient than equivalent capsule formulations. This quality gap is the most important factual consideration for any consumer choosing between gummy and capsule forms of the same supplement.

Format Preferences by Motivation

Primary Supplement Goal	Most Preferred Format	Second Choice
General wellness	Capsule/softgel	Gummy
Athletic performance	Powder	Capsule
Sleep support	Gummy	Capsule
Energy	Capsule	Powder
Longevity/aging	Capsule	Softgel
Cognitive performance	Capsule	Sublingual
Gut health (probiotic)	Capsule	Powder

Quality, Trust, and the Standards Americans Apply

The most consequential behavioral shift documented in the 2026 consumer survey is not what Americans are taking, or how much they are spending — it is how they are evaluating the products they purchase.

Quality Evaluation Behaviors (% of Supplement Users)

Quality Check	% Who Report Performing This	Change vs. 2022
Look for third-party testing seal	49%	+21 pts
Research brand reputation online	44%	+12 pts
Check ingredient sourcing/origins	34%	+8 pts
Review clinical research for ingredient	28%	+9 pts
Request certificate of analysis	12%	+7 pts
Consult pharmacist before purchase	24%	+3 pts
Rely on healthcare provider recommendation	41%	+4 pts
Rely on online customer reviews	38%	−6 pts
Rely on social media recommendation	22%	+4 pts
Rely on family/friend recommendation	18%	−3 pts

Third-party certification seeking has nearly doubled since 2022 — from 28% to 49% of supplement users actively checking for certification before purchase. This is perhaps the most consequential quality trend in the current data: when nearly half the market demands third-party verified products, manufacturers face a meaningful commercial incentive to actually obtain certification, which involves independent testing for label accuracy, contaminant absence, and in some cases bioavailability.

The simultaneous 6-point decline in reliance on online customer reviews reflects a growing awareness — accelerating in the context of documented fake review ecosystems on major e-commerce platforms — that anonymous consumer reviews are an unreliable proxy for product quality.

Consumer Confidence in Supplement Safety and Efficacy

Statement	% Who Agree	% Who Disagree	% Unsure
"I trust the supplements I take are safe"	67%	14%	19%
"I believe my supplements are effective for my goals"	61%	18%	21%
"I understand how my supplements work biologically"	31%	41%	28%
"I think the supplement industry is adequately regulated"	29%	48%	23%
"I believe FDA should approve supplements before sale"	64%	19%	17%

The gap between the 64% who believe the FDA should approve supplements before sale and the 29% who think the industry is adequately regulated reveals a persistent and consequential consumer misunderstanding: a majority of Americans believe pre-market regulatory review exists when it largely does not. This misperception does not make supplements dangerous in absolute terms, but it does create a false sense of regulatory protection that reduces consumer motivation to independently verify product quality — creating exactly the conditions in which quality failures thrive.

Expert Commentary: What Clinicians and Researchers Think of These Trends

• A primary care physician with over two decades of practice in urban internal medicine and a growing integrative medicine subspecialty reflected in the survey findings:
  • "What this data is telling me is that my patients are increasingly bringing me supplement questions that are far more sophisticated than what I was hearing even five years ago. They're not asking, 'should I take a multivitamin?' They're asking, 'Is this specific ashwagandha extract at this withanolide percentage going to interact with my levothyroxine?' That requires a different kind of clinical conversation — one that most medical training has not adequately prepared physicians to have. The data on third-party certification awareness is encouraging, but the gap between what consumers know and what they need to know is still significant."
• A registered dietitian who works with a large health system and has published extensively on supplement consumer behavior noted the spending data's implications:
  • "The average supplement user spending $57 a month is making a $684 annual financial commitment to products that — if we're honest about the distribution of evidence across the market — vary enormously in their scientific support. Some of that money is being very well spent on things that have good clinical evidence and will likely help. A meaningful portion is going to products where the evidence is thin, and the marketing is thick. The tragedy isn't that people are buying supplements; it's that they often can't tell the difference between the two."
• A clinical researcher specializing in nutrition science and supplement pharmacology at a major research university offered this perspective on the energy supplement trends:
  • "The shift away from caffeine toward adaptogens and mitochondrial support is, from a scientific standpoint, a mixed blessing. The evidence for ashwagandha and rhodiola rosea is genuinely solid — these compounds have mechanism and clinical trial support. The evidence for some of the newer 'cellular energy' compounds being marketed is much more preliminary. What worries me is that consumers are making this transition based more on the appeal of the narrative — 'supporting your mitochondria' sounds better than 'caffeine' — than on comparative evidence. The narrative sophistication is ahead of the evidence sophistication."
• A sleep medicine specialist who has followed the melatonin dosing data for years expressed specific concern:
  • "An average reported dose of 4.8 milligrams is pharmacologically very different from what the sleep research literature supports. At that dose, melatonin is functioning more like a sedative than a circadian signal — which is not what it is designed to do physiologically, and which is why so many people report grogginess the next morning. The commercial dosing of melatonin in the United States has been driven by manufacturing economics and consumer expectations, not by sleep science. This survey is confirming what we see clinically every day."
• A market analyst who tracks supplement industry investment and acquisition trends observed:
  • "The 41% of energy supplement users who started in the past two years, and the 34% of sleep supplement users who started during or after COVID — these are not going back. These are permanent additions to the supplement consumer base. The question is whether the industry can maintain the trust of this newly expanded cohort by demonstrating the quality improvements and evidence generation that sophisticated consumers increasingly demand. The brands that invest in both over the next three years are going to capture market leadership. The ones that don't are going to face an increasingly skeptical consumer on one side and tightening regulatory pressure on the other."

The Personalization Inflection Point

One of the most forward-looking findings in this year's survey is the rapid growth of personalized supplementation — both as a consumer aspiration and as a commercial reality. 23% of supplement users in 2026 report using some form of personalized supplement service, up from 14% in 2024 and just 4% in 2020. These services range from simple questionnaire-based custom supplement packs to more sophisticated protocols informed by blood biomarker testing, pharmacogenomic data, or comprehensive microbiome analysis.

Personalization Approach Distribution (Among Personalized Supplement Users)

Approach	% of Personalized Supplement Users
Questionnaire-based custom packs	52%
Blood biomarker-informed protocol	31%
Pharmacogenomic / genetic testing	18%
Microbiome analysis-based	14%
Wearable device-integrated (HRV, CGM)	9%
Healthcare provider-designed protocol	22%

Personalized supplement users spend an average of $94 per month — 65% more than the overall user average — and report meaningfully higher satisfaction rates (71% report significant benefit vs. 51% for non-personalized users). Whether this satisfaction differential reflects superior efficacy from personalized approaches, a placebo effect amplified by greater investment and engagement, or simply selection bias (more motivated, health-engaged consumers seeking out personalization services) cannot be definitively determined from this survey data. But the behavioral and commercial reality is clear: personalization is becoming a defining feature of the premium supplement market.

The GLP-1 Effect: A New Supplement Consumer Profile Emerges

No survey of American supplement behavior in 2026 is complete without addressing the extraordinary pharmaceutical development that is reshaping adjacent health markets: the widespread adoption of GLP-1 receptor agonist medications for obesity management.

Of the 8.4% of survey respondents who reported current use of GLP-1 medications, 84% are also taking dietary supplements — a use rate significantly above the general population average of 69.4%. More importantly, the supplement profile of GLP-1 medication users is distinctly different from the general supplement consumer:

Supplement Profile: GLP-1 Medication Users vs. General Population

Supplement	GLP-1 Users	General Population	Difference
Protein powder	67%	23%	+44 pts
Multivitamin	71%	52%	+19 pts
B12 / B Complex	54%	28%	+26 pts
Iron	38%	14%	+24 pts
Magnesium	48%	31%	+17 pts
Digestive enzymes	34%	8%	+26 pts
Probiotics	44%	26%	+18 pts
Zinc	31%	22%	+9 pts

This profile — heavy on protein supplementation, B vitamins, iron, and digestive support — directly reflects the nutritional consequences of dramatically reduced caloric intake: protein adequacy becomes challenging, micronutrient intake falls with food volume, and altered gut motility creates both digestive discomfort and absorption changes. The supplement industry's rapid recognition and commercial response to this new consumer segment represents one of the more legitimate cases of supplements meeting real, evidence-supported nutritional needs.

Looking Ahead: Projections for 2027

Based on trajectory analysis of current survey data and market dynamics, several specific developments appear probable for the 2027 supplement consumer landscape:

• Magnesium will surpass omega-3 as the third most used supplement. Its six-point growth in 2026 and continued momentum across sleep, stress, and cardiovascular applications in all age groups project it toward third place nationally, potentially overtaking omega-3 as evidence for omega-3 in primary cardiovascular prevention continues to be recalibrated downward while magnesium's diverse applications drive broader adoption.
• The longevity supplement category will cross $12 billion in U.S. retail sales. Current trajectory analysis suggests a doubling from 2024 to 2026 levels. The category is beginning to attract serious pharmaceutical-grade research investment, which will generate both positive evidence and high-profile negative results — with the latter likely producing the first meaningful quality contraction in the longevity supplement segment.
• Third-party certification will become a de facto requirement for retail shelf placement in premium channels. The 49% of consumers currently checking for certification before purchase is approaching the commercial threshold at which premium retailers have sufficient consumer demand to justify — and enforce — certification as a listing requirement rather than a differentiating feature.
• The melatonin dose correction will arrive. As awareness grows of the gap between commercial dosing practices and sleep science recommendations, a product reformulation wave toward lower-dose melatonin formats (0.5–2 mg) is likely. Consumer education around appropriate dosing — accelerating through healthcare provider channels and science-oriented media — should drive meaningful behavioral change in this specific area.

Conclusion: Reading America's Supplement Habits Honestly

The 2026 U.S. Dietary Supplement Consumer Report documents a consumer population that is, in measurable ways, more engaged, more sophisticated, and more financially committed to supplement use than at any previous point in the industry's history. More Americans are taking supplements. They are taking more of them. They are spending more on them. And they are asking harder questions about the products they buy — questions about third-party verification, ingredient quality, clinical evidence, and individual appropriateness that the industry is only partially equipped to answer honestly.

The data tells several stories simultaneously, and the intellectual integrity of this report requires holding all of them at once.

• It tells the story of genuine scientific progress: several of the compounds showing the strongest consumer growth — magnesium glycinate, ashwagandha, creatine, specific probiotic strains — also have genuinely strong clinical evidence that justifies the enthusiasm. The alignment between what science supports and what consumers are reaching for has never been better for a meaningful portion of the market.
• It tells the story of persistent gaps: melatonin doses that are nearly ten times what sleep research recommends. Quality failure rates in the uncertified product market that would be unacceptable in any other consumer health category. Consumer confidence in regulatory protection that significantly outstrips the actual oversight that exists.
• And it tells the story of genuine transformation: a new generation of American supplement consumers who are using personalized blood panels, genetic data, wearable biomarker tracking, and clinical research to make supplement decisions with a sophistication that would have been extraordinary a decade ago and is becoming increasingly ordinary.

The supplement cabinet of 2026 is not one thing. It contains products that are genuinely helping people, harmlessly expensive products, and products that the evidence has not yet caught up with — in both directions. The consumer who can tell the difference between these three categories is the consumer who benefits. The industry that earns their trust by being honest about the distinctions is the industry that will lead the next decade.

Appendix: Full Statistical Tables

Supplement Use Rate by U.S. Region (2026)

Region	% Using Supplements	Avg. Monthly Spend	Top Category
Northeast	71%	$62	Vitamins/Minerals
Southeast	67%	$54	Vitamins/Minerals
Midwest	66%	$51	Multivitamins
Southwest	70%	$58	Energy supplements
West	74%	$64	Adaptogens/Botanicals
Mountain/Plains	68%	$53	Multivitamins

Supplement Use Rate by Household Income

Household Income	% Using Supplements	Avg. Monthly Spend
Under $35,000	58%	$31
$35,000–$59,999	65%	$44
$60,000–$99,999	72%	$58
$100,000–$149,999	78%	$74
$150,000+	83%	$102

Supplement Use Rate by Education Level

Education Level	% Using Supplements
Less than high school diploma	51%
High school diploma / GED	61%
Some college	68%
Bachelor's degree	74%
Graduate/professional degree	79%

Satisfaction Rate by Supplement Category

Supplement Category	% Reporting Significant Benefit	% Reporting No Benefit
Iron (confirmed deficiency)	78%	8%
Vitamin D (confirmed deficiency)	74%	9%
Protein powder (with training)	71%	11%
Creatine (with training)	68%	14%
Magnesium (sleep/stress)	59%	17%
Probiotics (digestive complaints)	54%	22%
Ashwagandha (stress/sleep)	52%	21%
Sleep supplements (overall)	51%	18%
Energy supplements (overall)	48%	23%
Collagen (skin/joint)	42%	28%
General multivitamin	39%	29%
NMN / NAD+ precursors	36%	31%